HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
grifolan
beta-1,3-glucan from Grifola frondosa
Also Known As:
grifolan NMF-5N
Networked:
4
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Carbohydrates: 22023
Polysaccharides: 15383
Glucans: 1624
beta-Glucans: 499
grifolan: 4
Related Diseases
1.
Neoplasms (Cancer)
06/01/1988 - "
Next, 3H-grifolan (I/B) was injected into tumor-bearing mice 7 d after the tumor inoculation, which is the most effective administration timing for the antitumor effect of grifolan NMF-5N.
"
02/01/1987 - "
These results suggest that antitumor activities of grifolan NMF-5N in murine syngeneic tumor systems depend on not only dosage but also injection routes and timing.
"
02/01/1987 - "
Grifolan NMF-5N exhibited antitumor activities against these two syngeneic tumors by intraveneous (i.v.) injection.
"
02/01/1987 - "
Grifolan NMF-5N showed antitumor activities in allogeneic and syngeneic murine tumor systems.
"
02/01/1987 - "
In the allogeneic tumor system, a potent antitumor activity over 95% was observed against the solid form of sarcoma 180 when grifolan NMF-5N was injected intraperitoneally (i.p.) at 25-200 micrograms/mouse daily for 10 successive days.
"
2.
Sarcoma 180
06/01/1987 - "
Effect of grifolan on the ascites form of Sarcoma 180.
"
02/01/1987 - "
In the allogeneic tumor system, a potent antitumor activity over 95% was observed against the solid form of sarcoma 180 when grifolan NMF-5N was injected intraperitoneally (i.p.) at 25-200 micrograms/mouse daily for 10 successive days.
"
3.
Hypersensitivity (Allergy)
11/01/1987 - "
The delayed-type hypersensitivity reaction was augmented in the grifolan NMF-5N-administered mice.
"
4.
Ascites
06/01/1987 - "
Effect of grifolan on the ascites form of Sarcoma 180.
"
Related Drugs and Biologics
1.
Cytostatic Agents
2.
Polysaccharides (Glycans)
3.
Complement System Proteins (Complement)
Related Therapies and Procedures
1.
Intraperitoneal Injections